Voyager Therapeutics, Inc. (VYGR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92915B1061
Voyager Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 40.37 m USD |
| Operating income | -131.84 m USD |
| EBIT | -119.58 m USD |
| Net income | -119.72 m USD |
| Diluted EPS – continuing operations | -2.04 USD |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
More stocks
- RAC Electric Vehicles Inc. (2237.TWO)
- Joyce Corporation Ltd (JYC.AX)
- Data Communications Management Ltd (DCM.TO)
- Sunspring Metal Corp (2062.TW)
- Changsha Kaiyuan Instruments (300338.SZ)
- Empresas Iansa S.A (IANSA.SN)
- Chernan Metal Industrial (3631.TWO)
- KB Star REIT Co. Ltd. (432320.KS)
- Prime Electronics & Satellitics Inc (6152.TW)
- CSU Digital S.A. (CSUD3.SA)
- Eloro Resources Ltd. (ELO.TO)
- Daechang Forgi (015230.KS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.